These results underscore the ability to utilize L1CAM as a quantitative biomarker for brain‐derived EVs detected by the EVID‐biochip, offering a promising approach for early and accurate diagnosis of neurodegenerative disorders such as PD. This evidence concerns the gene L1CAM and Parkinson disease.